Michael F. Mahoney
Michael Mahoney is President and Chief Executive Officer of Boston Scientific Corporation and a member of its Board of Directors. In this role, Mahoney oversees all aspects of the global development, marketing and sales of the company's broad portfolio of medical device solutions. Mahoney assumed this role in November, 2012.
Previously, Mahoney served as President of Boston Scientific. In that capacity, he was specifically responsible for the company's Cardiac Rhythm Management (CRM) and Endoscopy (GI and Pulmonary) businesses, as well as certain corporate functions.
Mahoney joined the company in October 2011, having established a 24-year track record building market leading global businesses in medical devices, capital equipment, and healthcare IT service businesses at best-in-class companies.
Prior to joining Boston Scientific, he was Worldwide Chairman of the Medical Devices and Diagnostics (MD&D) division of Johnson & Johnson, overseeing 50,000 employees and seven franchises. Previously, Mahoney served as Worldwide Group Chairman of Johnson & Johnson's DePuy franchise, a leading orthopedics and neuro-sciences business, where he successfully drove growth via product innovation, multiple acquisitions, and International expansion, particularly in China and India.
Prior to joining Johnson & Johnson, Mahoney served as President and Chief Executive Officer of Global Healthcare Exchange (GHX), a leading provider of supply chain solutions and services that bring together hospitals, manufacturers, distributors and GPOs. He built the company through organic development and strategic acquisitions, successfully integrating seven acquisitions and expanding the business into Europe and Canada.
Mahoney built his early career at General Electric Medical Systems, where he spent 12 years, in a variety of advancing leadership roles for domestic and global businesses in CT, MRI, X-ray, Healthcare IT, and Nuclear Medicine, culminating in the role of General Manager of the Healthcare Information Technology business.
Mahoney earned a B.B.A. in Finance from the University of Iowa and a M.B.A. from Wake Forest University. He is married and has three children.
Kevin Ballinger is Senior Vice President and Global President, Interventional Cardiology for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for developing and bringing to market innovative solutions that diagnose and treat coronary artery disease and cardiac valve disorders.
Ballinger has more than 17 years of interventional cardiology experience. Prior to his current role, he held a variety of engineering and general management positions within Boston Scientific’s Interventional Cardiology business unit, including overseeing the development of the company’s first drug-eluting stents.
Ballinger earned a B.S. in Mechanical Engineering from Michigan Tech University and an MBA from the University of Minnesota.
Supratim Bose is Executive Vice President and President, Asia-Pac, Middle East and Africa (AMEA)for Boston Scientific and a member of its Executive Committee. In this role, Supratim oversees the Company’s business and growth opportunities across Asia-Pacific, the world’s fastest growing region, plus the Middle East and Africa.
Before joining Boston Scientific in January 2012, Supratim was Founder and Chief Executive Officer of Singapore-based Bose Consulting Group, which specialized in strategic management consulting services for the healthcare industry. Previously, he worked for nearly 30 years at Johnson & Johnson, where he concluded his tenure as Company Group Chairman of its Medical Devices and Diagnostics (MD&D) business. In this role, he managed Johnson & Johnson’s MD&D companies throughout Asia-Pacific, including Japan, having pioneered its entry in all emerging markets in Asia, including China, India, and Vietnam. During his tenure, he also created the company’s research and development capability in the region and led the development and growth of local talent. Under Supratim’s leadership, the organization partnered closely with key external stakeholders to shape the healthcare environment, and was recognized by external agencies as one of the top companies to work for in Asia-Pacific.
Supratim joined Johnson & Johnson Ltd. India in 1981, and held a variety of management positions of increasing responsibility leading up to his appointment as Company Group Chairman of MD&D. He has extensive and proven experience in building markets in this region. Prior to J&J, he served at one of the top growing pharmaceutical start-ups in India.
Supratim earned a B.S. in Chemistry/Physics, a M.S. in Biophysics and a Master in Management Studies from the Jamnalal Bajaj Institute of Management Studies at the University of Bombay. He served as a a member of the Board of Directors at Quattro Vascular Pte Ltd and Trireme Medical, and member of the Advisory Board at Singapore Management University’s Lee Kong Chian School of Business. He continues to teach at the Nanyang Business School, Singapore, as a visiting faculty member.
Asia-Pac, Middle East
and Africa (AMEA)
Daniel J. Brennan
Daniel Brennan is Executive Vice President and Chief Financial Officer for Boston Scientific Corporation and a member of its Executive Committee. In this role, he is responsible for several Company functions, including Global Controllership, Corporate Finance, Treasury, Corporate Tax, Corporate Analysis and Control, and Corporate New Business Development.
Previously, he served as Senior Vice President and Corporate Controller. In this role, Brennan was responsible for the Global Controllership organization, including the Company’s accounting and financial planning processes.
Brennan joined Boston Scientific in 1996 and has served in a number of financial roles of increasing responsibility, including Assistant Corporate Controller; Vice President-Worldwide Financial & Strategic Planning; Vice President-Investor Relations, Vice President-International Finance and Vice President-Finance & Information Technology for the company’s Cardiovascular Division.
Prior to joining Boston Scientific, Brennan held several finance positions at Millipore Corporation and Standex Corporation.
Brennan is a Certified Public Accountant and earned his B.S. in Finance and Investments and his M.B.A. from Babson College.
Chief Financial Officer
Wendy Carruthers is Senior Vice President of Human Resources for Boston Scientific Corporation and a member of its Executive Committee. In this role, she oversees the company’s human resources activities globally, including HR operations and services, total rewards, talent management, and diversity and inclusion.
Prior to her current role, Carruthers served since January 2011 as Vice President of Global Talent Management for Boston Scientific, responsible for all aspects of global talent management including the design, development and implementation of global processes and systems to enable managers to identify, attract, leverage and develop people.
Carruthers has been with Boston Scientific since 2004 and was previously Vice President of Human Resources for the company’s Europe, Middle East and Africa (EMEA) region, based in Paris.
Prior to joining Boston Scientific, Carruthers was Vice President of Human Resources, Europe for global telecommunications company Cable & Wireless. She also previously worked in human resources for Diageo, a food and beverage company, and Tesco, a U.K. supermarket chain.
A native of Great Britain, Carruthers has lived and worked in the U.K., France, Italy, Australia and the United States. She holds a B.A. First Class Honors Degree in Modern Languages and is a graduate member of the Chartered Institute of Personnel and Development.
Keith D. Dawkins, M.D.
Keith Dawkins, M.D., is Executive Vice President and Global Chief Medical Officer for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for enhancing the Company’s global Clinical programs and strategies.
Prior to his current role, which he assumed in January 2012, Dr. Dawkins was Chief Medical Officer of Boston Scientific’s Cardiology, Rhythm and Vascular Group. He joined Boston Scientific in 2008 as Senior Vice President and Associate Chief Medical Officer for the Company’s Cardiovascular (CV) business. While in this role, he led Boston Scientific’s Clinical Integration Project, which brought together its former CV and Cardiac Rhythm Management Clinical organizations under the Company’s CRV Group.
Prior to joining Boston Scientific, Dr. Dawkins was a practicing interventional cardiologist for more than 20 years in England. He has earned a series of clinical, research and academic distinctions, including a Post-Doctoral Research Fellowship at Stanford University as a Fulbright Scholar. Dr. Dawkins served as President of the British Cardiovascular Intervention Society, and held numerous appointments on hospital, regional and national committees, including the National Institute for Health and Clinical Excellence (NICE). He has been an author on more than 450 academic publications and presentations on a variety of cardiac topics.
Dr. Dawkins earned a First-Class Honours degree in Pathology at London University and Guys Hospital. He trained in cardiology at Oxford and at the Brompton & St. George’s Hospital in London.
Global Chief Medical Officer
Joseph M. Fitzgerald
Joe Fitzgerald is Executive Vice President and President, Rhythm Management for Boston Scientific and a member of its Executive Committee.
Prior to his current role, Fitzgerald was President of Boston Scientific's Endovascular Unit, which included the Company's Peripheral Interventions, Electrophysiology, Neurovascular and IVUS businesses. Previously, he held a number of senior leadership positions at Boston Scientific, including President of our Electrophysiology business and Vice President of Global Marketing and U.S. Sales for the Company's Neurovascular business.
Fitzgerald joined Boston Scientific in 1990 as a sales representative and subsequently held a variety of sales leadership positions in the Company's Peripheral Interventions business, including U.S. Sales and Operations Manager.
He earned a B.S. in Business from Indiana University and a M.B.A. from Southern Illinois University with a concentration in Marketing and Finance.
Jean Fitterer Lance
Jean Lance is Senior Vice President and Chief Compliance Officer for Boston Scientific and a member of its Executive Committee. In this role, she oversees the Company’s Global Compliance function, which is committed to maintaining a best-in-class compliance and ethics program across all Boston Scientific business groups and locations, including the Company’s interactions with health care professionals.
Prior to assuming her current role, Lance served as Vice President and General Counsel for the Company’s Cardiovascular Group. Before joining Boston Scientific in 1996, she was General Counsel and Vice President of Human Resources for Red Line Healthcare Corporation. Previously, Lance practiced with the national law firm of Sonnenschein Nath & Rosenthal in Chicago, Illinois, where she specialized in corporate law with an emphasis in health law.
Lance earned a B.S. in Accounting from Minnesota State University – Mankato. She earned a law degree, with honors, from the University of Minnesota Law School, where she was a member of The University of Minnesota Law Review.
Lance is a member of the Advanced Medical Technology Association’s ("AdvaMed") Code of Ethics Working Group and has been actively engaged in the development of the AdvaMed Code of Ethics on Interactions with health care professionals and the 2008 revisions to the AdvaMed Code of Ethics.
Chief Compliance Officer
Jeff Mirviss is Senior Vice President and President, Peripheral Interventions for Boston Scientific and a member of its Executive Committee. In that capacity he is responsible for developing and bringing to market innovative solutions for treating patients with high blood pressure, vascular system blockages and cancer.
Mirviss has more than 23 years of experience in medical device and pharmaceutical general management, marketing and sales. He has held positions of increasing responsibility since 1997 at Boston Scientific.
In addition to his roles at Boston Scientific, Mirviss has worked for companies ranging in size from a pre-revenue venture-backed medical device startup to Dow 30 companies.
A resident of Plymouth, Minn., Mirviss holds a Bachelor’s degree from the University of Minnesota and an MBA from the University of St. Thomas.
Maulik Nanavaty is Senior Vice President and President, Neuromodulation Division for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for the innovation leader in less-invasive microelectronic implantable technologies used to treat chronic neuropathic pain.
Prior to his current role, Nanavaty was President, Representative Director of Boston Scientific Japan. Previously, he was Vice President and General Manager of the Company's Interventional Cardiology business in Japan. During his tenure, Nanavaty managed the successful expansion of Cardiology business in that country. He joined Boston Scientific in 2005 as Vice President for Corporate Strategy for Japan, where he led business transformation and increased operational efficiency.
Prior to joining Boston Scientific, Nanavaty spent 16 years working in various executive positions at Baxter International, Inc., and Baxter Japan.
Nanavaty earned a Ph.D. in Pharmaceutical Sciences from the University of Illinois and a M.B.A. from the University of Chicago.
Nanavaty is a member of the Board of Directors for the California Health Institute (CHI). CHI is an independent 501(c)(6) organization devoted to researching and advocating policy to forward the interests of California's biomedical community.
J. Michael Onuscheck
Michael Onuscheck is Senior Vice President and President, Europe for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for Boston Scientific’s businesses in Europe.
Prior to his current role, Onuscheck was Senior Vice President and President, Boston Scientific’s Neuromodulation Division, where he was responsible for research and development, manufacturing, marketing, sales, clinical research and customer service. Previously, he was Vice President of Sales and Marketing for Boston Scientific’s Pain Management business. In this role, he led the commercial launch of the Precision™ Spinal Cord Stimulation System for intractable pain, and helped create the Company’s spinal cord stimulation business. Onuscheck has also led the field sales and clinical organization, marketing and communications function, field clinical engineering team, technical support team, and training and education department.
He joined the Company in 2004 with Boston Scientific’s acquisition of Advanced Bionics, where he had been serving as Vice President of Sales and Clinical Services in the Company’s Auditory business.
Prior to joining Boston Scientific, Onuscheck held a variety of management positions at Medtronic in spinal reconstructive surgery and stereotactic image guided surgery. Before that, he worked for Pfizer, where he held various sales and marketing positions.
Onuscheck earned a B.A. in Business Administration and Psychology from Washington and Jefferson College.
Michael P. Phalen
Michael Phalen is Executive Vice President and President, Medical Surgery (MedSurg) for Boston Scientific and a member of its Executive Committee. In this role, he plans and executes Boston Scientific’s growth strategies for the Company’s Endoscopy, Urology/Women’s Health and Neuromodulation businesses. Phalen also oversees Boston Scientific operations in Canada and Latin America.
Prior to assuming his current position in January 2012, Phalen was President of Boston Scientific International. He was responsible for planning and executing Boston Scientific’s international growth strategy.
Phalen joined Boston Scientific in 1988 and held various management positions of increasing responsibilities including Territory Manager, Product Manager, Regional Sales Manager, Group Product Manager, Director of Marketing, Vice President of Global Marketing and Senior Vice President and President of the company’s Endoscopy division.
Before joining Boston Scientific, Phalen held management positions with MD Technology, Kendall Healthcare and Pennwalt Pharmaceuticals. He earned a B.S. in General Science from Villanova University and an M.B.A. from Fairleigh Dickinson University.
David A. Pierce
Dave Pierce is Senior Vice President and President, Endoscopy Division for Boston Scientific and a member of its Executive Committee. In this role, he develops and executes strategies for the Endoscopy business.
Prior to his current role, he was Endoscopy Vice President of Global Marketing, managing product marketing, communications and programs, market development, new business development and customer education. Pierce joined the Company in 1991 as a Territory Manager before assuming various management-level positions of increasing responsibility.
Before joining Boston Scientific, Pierce worked as a Senior Sales Representative for Airborne Express and served as a Captain in the United States Army.
Pierce earned a B.S. in Business Administration from Norwich University and a M.B.A. from Boston University.
Karen Prange is Senior Vice President and President, Urology & Women’s Health for Boston Scientific and a member of its Executive Committee. In this role, she is responsible for developing and bringing to market innovative solutions for the treatment of various urological and gynecological disorders.
Prior to her current role, Ms. Prange spent 17 years with Johnson & Johnson in various medical device businesses and has been recognized as a results-driven leader with a significant track record in delivering multiple cycles of business results via strategic change and re-alignment, sales growth, market development, portfolio strategy and global product commercialization.
The recipient of a BS in Business Administration with honors from the University of Florida, Prange has also completed executive education coursework at UCLA Anderson School of Business and Smith College.
Urology & Women’s Health
Timothy A. Pratt
Tim Pratt is Executive Vice President, Chief Administrative Officer, General Counsel and Secretary for Boston Scientific and a member of its Executive Committee. In this role, he is responsible for worldwide management of Boston Scientific’s Legal functions, Global Regulatory Affairs, Government Affairs, Enterprise Strategy and Marketing, Health Economics and Reimbursement, Corporate Communications, and Aviation.
Mr. Pratt is active in the Federation of Defense and Corporate Counsel ("FDCC"), where he serves on the Board, Executive Committee, and as their President. He also serves as a Director on the Boards of Lawyers for Civil Justice ("LCJ"), DRI - The Voice of the Defense Bar, and the New England Legal Foundation ("NELF"). Mr. Pratt is a past member of the Board of Directors for the Advanced Medical Technology Association ("AdvaMed") and also served on their Executive Committee.
Mr. Pratt earned his Bachelor of Arts degree at Tarkio College and graduated Order of the Coif from Drake University Law School, where he served as editor-in-chief of the Drake Law Review. Prior to joining Boston Scientific in 2008, Mr. Pratt was a partner and trial attorney with the law firm of Shook, Hardy & Bacon. While there, he was named a Leading National Products Liability Lawyer by Chambers USA, one of the Top 500 Litigators in America by Lawdragon, and one of the Best Lawyers in America. In October of 2013, he was recognized by The Legal 500 and named to the "Corporate Counsel 100" list, which identifies the top most powerful corporate legal advisers in the United States.
Chief Administrative Officer,
General Counsel and Secretary
Kenneth J. Pucel
Ken Pucel is Executive Vice President of Global Operations, Quality and Technology for Boston Scientific and a member of its Executive Committee. In this role, he directs the Company’s manufacturing, distribution and supply chain operations and manages Corporate Research and Development (R&D) and the R&D product development processes.
Pucel joined Boston Scientific in 1989 and has held various positions of increasing responsibility, including Manufacturing Engineer, Process Development Engineer, Operations Manager, Production Manager and Director of Operations. He has also worked as Vice President of Operations, Multi-Site Vice President of Operations, Senior Vice President of Operations and Executive Vice President of Global Operations.
Pucel earned a B.S. in Mechanical Engineering, with a concentration in Biomedical Engineering, from the University of Minnesota.
Quality and Technology